Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Poland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20101
20111
20132
20172
20182
20191
20201
20212
20221
20231
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting6
Active, not recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Merck Sharp & Dohme LLC3
pharmaand GmbH3
Amgen2
Corcept Therapeutics2
Eli Lilly and Company2
Affidea Nu-med Center of Oncological DIagnostics and Therapy1
Daiichi Sankyo1
Genmab1
Glycotope GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms24
Ovarian Neoplasms20
Carcinoma, Ovarian Epithelial9
Peritoneal Neoplasms9
Neoplasms4
Recurrence2
Endometrial Neoplasms1
Fallopian Tube Diseases1
Fistula1
Genital Neoplasms, Female1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.